Rapid Dose Therapeutics Corp. (DOSE.CN)
- Business Wire
Rapid Dose Therapeutics Reports Fiscal Year 2023 Financial Results
BURLINGTON, Ontario, June 28, 2023--Rapid Dose Therapeutics Corp. ("RDT" or the "Company") (CSE: DOSE), today reported its financial results for the year ended February 28, 2023.
- Business Wire
Rapid Dose Announces Increased Proposed Private Placement Financing of up to $5,000,000
BURLINGTON, Ontario, June 13, 2023--Rapid Dose Therapeutics Corp. ("RDT" or the "Company") (CSE: DOSE) today announced that further to its press release dated June 2, 2023, it plans to complete an increased private placement financing (the "Financing") for up to $5,000,000 of gross proceeds (an increase from $3,000,000), consisting of up to 5,000,000 units (the "Units") at a price of $1.00 per Unit. Each Unit will consist of $1.00 principal amount of secured convertible notes (the "Notes") and f
- Business Wire
Rapid Dose Announces Proposed Private Placement Financing
BURLINGTON, Ontario, June 03, 2023--Rapid Dose Therapeutics Corp. ("RDT" or the "Company") (CSE: DOSE) today announced that it plans to complete a private placement financing (the "Financing") for up to $3,000,000 of gross proceeds, consisting of up to 3,000,000 units (the "Units") at a price of $1.00 per Unit. Each Unit will consist of $1.00 principal amount of secured convertible notes (the "Notes") and five (5) common share purchase warrants of the Company (the "Warrants"). The Financing may
